156 related articles for article (PubMed ID: 24630139)
1. The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males.
Koiliari E; Roussos P; Pasparakis E; Lencz T; Malhotra A; Siever LJ; Giakoumaki SG; Bitsios P
Schizophr Res; 2014 Apr; 154(1-3):42-7. PubMed ID: 24630139
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Donohoe G; Walters J; Hargreaves A; Rose EJ; Morris DW; Fahey C; Bellini S; Cummins E; Giegling I; Hartmann AM; Möller HJ; Muglia P; Owen MJ; Gill M; O'Donovan MC; Tropea D; Rujescu D; Corvin A
Genes Brain Behav; 2013 Mar; 12(2):203-9. PubMed ID: 23320435
[TBL] [Abstract][Full Text] [Related]
3. Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Rose EJ; Morris DW; Hargreaves A; Fahey C; Greene C; Garavan H; Gill M; Corvin A; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):530-7. PubMed ID: 23839771
[TBL] [Abstract][Full Text] [Related]
4. No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population.
Liu Y; Cheng Z; Wang J; Jin C; Yuan J; Wang G; Zhang F; Zhao X
BMC Psychiatry; 2016 Jul; 16():206. PubMed ID: 27377754
[TBL] [Abstract][Full Text] [Related]
5. Replicated association between the European GWAS locus rs10503253 at CSMD1 and schizophrenia in Asian population.
Liu W; Liu F; Xu X; Bai Y
Neurosci Lett; 2017 Apr; 647():122-128. PubMed ID: 28344127
[TBL] [Abstract][Full Text] [Related]
6. A genetic association study of CSMD1 and CSMD2 with cognitive function.
Athanasiu L; Giddaluru S; Fernandes C; Christoforou A; Reinvang I; Lundervold AJ; Nilsson LG; Kauppi K; Adolfsson R; Eriksson E; Sundet K; Djurovic S; Espeseth T; Nyberg L; Steen VM; Andreassen OA; Le Hellard S
Brain Behav Immun; 2017 Mar; 61():209-216. PubMed ID: 27890662
[TBL] [Abstract][Full Text] [Related]
7. Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.
Drgonova J; Walther D; Singhal S; Johnson K; Kessler B; Troncoso J; Uhl GR
PLoS One; 2015; 10(7):e0120908. PubMed ID: 26171607
[TBL] [Abstract][Full Text] [Related]
8. Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients.
Chen M; Xu Z; Zhai J; Bao X; Zhang Q; Gu H; Shen Q; Cheng L; Chen X; Wang K; Deng X; Ji F; Liu C; Li J; Dong Q; Chen C
Neuropsychopharmacology; 2012 Jun; 37(7):1572-8. PubMed ID: 22373944
[TBL] [Abstract][Full Text] [Related]
9. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.
Walters JT; Corvin A; Owen MJ; Williams H; Dragovic M; Quinn EM; Judge R; Smith DJ; Norton N; Giegling I; Hartmann AM; Möller HJ; Muglia P; Moskvina V; Dwyer S; O'Donoghue T; Morar B; Cooper M; Chandler D; Jablensky A; Gill M; Kaladjieva L; Morris DW; O'Donovan MC; Rujescu D; Donohoe G
Arch Gen Psychiatry; 2010 Jul; 67(7):692-700. PubMed ID: 20603450
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.
Steen VM; Nepal C; Ersland KM; Holdhus R; Nævdal M; Ratvik SM; Skrede S; Håvik B
PLoS One; 2013; 8(11):e79501. PubMed ID: 24244513
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
12. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
Rose EJ; Hargreaves A; Morris D; Fahey C; Tropea D; Cummings E; Caltagirone C; Bossù P; Chiapponi C; Piras F; Spalletta G; Gill M; Corvin A; Donohoe G
Br J Psychiatry; 2014 Feb; 204(2):115-21. PubMed ID: 24311551
[TBL] [Abstract][Full Text] [Related]
13. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.
Wonodi I; McMahon RP; Krishna N; Mitchell BD; Liu J; Glassman M; Hong LE; Gold JM
Schizophr Res; 2014 Dec; 160(1-3):80-7. PubMed ID: 25464917
[TBL] [Abstract][Full Text] [Related]
14. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.
Donohoe G; Walters J; Morris DW; Quinn EM; Judge R; Norton N; Giegling I; Hartmann AM; Möller HJ; Muglia P; Williams H; Moskvina V; Peel R; O'Donoghue T; Owen MJ; O'Donovan MC; Gill M; Rujescu D; Corvin A
Arch Gen Psychiatry; 2009 Oct; 66(10):1045-54. PubMed ID: 19805695
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients.
Liu Y; Fu X; Tang Z; Li C; Xu Y; Zhang F; Zhou D; Zhu C
BMC Psychiatry; 2019 Apr; 19(1):113. PubMed ID: 30987620
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood.
Hatzimanolis A; Bhatnagar P; Moes A; Wang R; Roussos P; Bitsios P; Stefanis CN; Pulver AE; Arking DE; Smyrnis N; Stefanis NC; Avramopoulos D
Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):392-401. PubMed ID: 25963331
[TBL] [Abstract][Full Text] [Related]
17. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
Walters JT; Rujescu D; Franke B; Giegling I; Vásquez AA; Hargreaves A; Russo G; Morris DW; Hoogman M; Da Costa A; Moskvina V; Fernández G; Gill M; Corvin A; O'Donovan MC; Donohoe G; Owen MJ
Am J Psychiatry; 2013 Aug; 170(8):877-85. PubMed ID: 23903335
[TBL] [Abstract][Full Text] [Related]
18. Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.
Spellmann I; Müller N; Musil R; Zill P; Douhet A; Dehning S; Cerovecki A; Bondy B; Möller HJ; Riedel M
Eur Arch Psychiatry Clin Neurosci; 2008 Sep; 258(6):335-44. PubMed ID: 18347838
[TBL] [Abstract][Full Text] [Related]
19. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level.
Stefanis NC; Trikalinos TA; Avramopoulos D; Smyrnis N; Evdokimidis I; Ntzani EE; Ioannidis JP; Stefanis CN
Biol Psychiatry; 2007 Oct; 62(7):784-92. PubMed ID: 17336946
[TBL] [Abstract][Full Text] [Related]
20. [Schizophrenia, genetics and cognition].
Belzeaux R; Ibrahim EC; Fakra E; Adida M; Cermolacce M; Azorin JM
Encephale; 2011 Dec; 37 Suppl 2():S127-32. PubMed ID: 22212842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
